Latest Distributions News

Magellan Investment Partners has launched the Airlie Australian Share Fund - Active ETF (AASF), offering investors a concentrated, actively managed portfolio of Australian equities with integrated ESG considerations. The fund combines liquidity via direct applications and Securities Exchange trading, targeting long-term capital growth and income.

Mirvac Group has announced a 4.7 cent per stapled security distribution from its Property Trust for the six months ending December 2025, payable in February 2026. Investors can choose to receive payments in Australian or New Zealand dollars.

Bendigo and Adelaide Bank has announced a fully franked quarterly dividend of AUD 1.311 per security on its Capital Note BENPH, payable in March 2026. This distribution reflects a steady income stream aligned with the terms set out in the 2020 prospectus.

Region Group has announced an ordinary unfranked distribution of AUD 0.069 per unit for the six months ending December 2025, payable in January 2026. The distribution excludes participation in the Dividend Reinvestment Plan.

Region Group announces a 6.9 cent per stapled security distribution for H1 FY26 and confirms its AFFO guidance of 14.0 cents per security for the full year.

Newmont Corporation has updated its dividend announcement to include currency exchange rates and payment instructions, clarifying tax withholding and payment options for investors.

Revolution Private Credit Income Trust has reported a solid $3.4 million operating profit for its inaugural half-year period, delivering a net return of 0.93% since listing and outperforming its benchmark. The Trust also declared a distribution of 0.35 cents per unit for October 2025.

Wellnex Life reports encouraging early results from its turnaround strategy, posting a modest EBITDA profit and robust sales growth for its Pain Away brand.

Bank of Queensland Limited has announced a fully franked quarterly distribution of AUD 1.2412 per Capital Note 3 security, payable in March 2026. The distribution reflects a 4.9784% annualised rate based on the BBSW plus a margin.

DroneShield has landed a $49.6 million contract to supply handheld counterdrone systems to a European military customer, with deliveries and payments expected to complete by Q1 2026.

4DMedical has gained Canadian regulatory approval for its innovative CT – VQ™ ventilation-perfusion imaging technology, enabling immediate commercial rollout through Philips and expanding its North American footprint.

Orthocell has lodged a regulatory application to distribute its nerve repair product Remplir™ across the EU and UK, aiming to tap into a $750 million market with approval expected by Q3 2026.